Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP.
Li, Zhi-Ming
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. [electronic resource] - PloS one 2012 - e41658 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0041658 doi
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Humans
Kaplan-Meier Estimate
Leukocyte Count
Lymphoma, Large B-Cell, Diffuse--blood
Male
Middle Aged
Monocytes--pathology
Multivariate Analysis
Prednisone--therapeutic use
Prognosis
Proportional Hazards Models
ROC Curve
Risk Factors
Rituximab
Treatment Outcome
Vincristine--therapeutic use
Blood lymphocyte-to-monocyte ratio identifies high-risk patients in diffuse large B-cell lymphoma treated with R-CHOP. [electronic resource] - PloS one 2012 - e41658 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
1932-6203
10.1371/journal.pone.0041658 doi
Aged
Antibodies, Monoclonal, Murine-Derived--therapeutic use
Antineoplastic Combined Chemotherapy Protocols--therapeutic use
Cyclophosphamide--therapeutic use
Doxorubicin--therapeutic use
Female
Humans
Kaplan-Meier Estimate
Leukocyte Count
Lymphoma, Large B-Cell, Diffuse--blood
Male
Middle Aged
Monocytes--pathology
Multivariate Analysis
Prednisone--therapeutic use
Prognosis
Proportional Hazards Models
ROC Curve
Risk Factors
Rituximab
Treatment Outcome
Vincristine--therapeutic use